-
EP3577132
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3577132
| EP3577132 - ONCOLYTIC VIRUS THERAPY [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 25.08.2023 Database last updated on 19.07.2024 | |
| Former | Request for examination was made Status updated on 08.11.2019 | ||
| Former | The international publication has been made Status updated on 11.08.2018 | Most recent event Tooltip | 16.02.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states University of Pittsburgh - Of the Commonwealth System of Higher Education 1st Floor Gardner Steel Conference Center 130 Thackeray Avenue Pittsburgh, PA 15260 / US | [2021/22] |
| Former [2019/50] | For all designated states University of Pittsburgh - of The Commonwealth System of Higher Education 1st Floor Gardner Steel Conference Center 130 Thackeray Avenue Pittsburgh, PA 15260 / US | Inventor(s) | 01 /
GUO, Zong, Sheng 2446 Wedgewood Drive Wexford PA 15090 / US | 02 /
BARTLETT, David 504 Old Orchard Trail Pittsburgh PA 15238 / US | 03 /
LIU, Zuqiang 9920 Belton Circle Apt. 204 Wexford PA 15090 / US | 04 /
FEIST, Mathilde c/o University Of Pittsburgh 1st Floor Gardner Steel Conference Center 130 Thackeray Avenue Pittsburgh PA 15260 / US | [2019/50] | Representative(s) | Fish & Richardson P.C. Highlight Business Towers Mies-van-der-Rohe-Straße 8 80807 München / DE | [N/P] |
| Former [2019/50] | Ammelburg, Jan Moritz c/o Fish & Richardson P.C. Highlight Business Towers Mies-van-der-Rohe-Straße 8 80807 München / DE | Application number, filing date | 18747947.2 | 05.02.2018 | [2019/50] | WO2018US16912 | Priority number, date | US201762454526P | 03.02.2017 Original published format: US 201762454526 P | [2019/50] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018145033 | Date: | 09.08.2018 | Language: | EN | [2018/32] | Type: | A1 Application with search report | No.: | EP3577132 | Date: | 11.12.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 09.08.2018 takes the place of the publication of the European patent application. | [2019/50] | Search report(s) | International search report - published on: | US | 09.08.2018 | (Supplementary) European search report - dispatched on: | EP | 08.02.2021 | Classification | IPC: | C07K14/47, C07K14/52, C12N7/01, C12N15/09 | [2019/50] | CPC: |
C07K14/55 (EP,KR);
A61K35/768 (EP,KR);
A61K35/763 (US);
A61K35/761 (US);
A61K38/191 (KR,US);
A61K38/2013 (KR,US);
A61K38/217 (KR,US);
A61K39/39 (EP);
A61K39/39558 (KR);
A61P35/00 (EP,KR);
C07K14/70532 (EP,KR);
C12N7/00 (KR);
A61K2039/505 (KR);
A61K2039/5256 (EP);
A61K2039/55533 (EP);
A61K2039/82 (EP);
A61K2039/876 (EP);
C07K2319/00 (EP,KR);
C12N2710/24132 (EP,KR)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/50] | Title | German: | ONKOLYTISCHE VIRUSTHERAPIE | [2019/50] | English: | ONCOLYTIC VIRUS THERAPY | [2019/50] | French: | THÉRAPIE À BASE DE VIRUS ONCOLYTIQUE | [2019/50] | Entry into regional phase | 03.09.2019 | National basic fee paid | 03.09.2019 | Search fee paid | 03.09.2019 | Designation fee(s) paid | 03.09.2019 | Examination fee paid | Examination procedure | 03.09.2019 | Examination requested [2019/50] | 31.08.2021 | Amendment by applicant (claims and/or description) | 25.08.2023 | Despatch of a communication from the examining division (Time limit: M04) | 03.01.2024 | Reply to a communication from the examining division | Fees paid | Renewal fee | 03.09.2019 | Renewal fee patent year 03 | 25.02.2021 | Renewal fee patent year 04 | 25.02.2022 | Renewal fee patent year 05 | 27.02.2023 | Renewal fee patent year 06 | 15.02.2024 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2014138314 (BAYLOR COLLEGE MEDICINE [US]) [A] 1-9 * abstract * * paragraph [0006] - paragraph [0007]; claims 1,8-11 *; | [A]WO2015027163 (UNIV PITTSBURGH [US]) [A] 1-9 * abstract * * page 2, line 25 - page 3, line 3; claims 19-24 *; | [A]WO2016146894 (TILT BIOTHERAPEUTICS OY [FI]) [A] 1-9 * abstract * * page 5, line 19 - line 22; figure 7; example 10; claims 10-18 *; | [XPI]WO2017044780 (TVAX BIOMEDICAL I LLC [US]) [XP] 1-8 * abstract * * page 4, line 18 - page 15, line 2 * * page 3, line 3 - line 8 * * page 8, line 15 - line 19 * * page 27, line 30 - page 28, line 33 * * page 31, line 11 - page 32, line 6 * * page 5, line 3 - line 22; figure 1 * [I] 9; | [I] - S. A. ROSENBERG ET AL, "Adoptive cell transfer as personalized immunotherapy for human cancer", SCIENCE, US, (20150403), vol. 348, no. 6230, doi:10.1126/science.aaa4967, ISSN 0036-8075, pages 62 - 68, XP055256712 [I] 8 * abstract * DOI: http://dx.doi.org/10.1126/science.aaa4967 | [A] - LINH T. NGUYEN ET AL, "Expansion and Characterization of Human Melanoma Tumor-Infiltrating Lymphocytes (TILs)", PLOS ONE, (20101110), vol. 5, no. 11, doi:10.1371/journal.pone.0013940, page e13940, XP055742005 [A] 1-9 * abstract * DOI: http://dx.doi.org/10.1371/journal.pone.0013940 | [A] - J POUTOU ET AL, "Safety and antitumor effect of oncolytic and helper-dependent adenoviruses expressing interleukin-12 variants in a hamster pancreatic cancer model", GENE THERAPY, GB, (20150504), vol. 22, no. 9, doi:10.1038/gt.2015.45, ISSN 0969-7128, pages 696 - 706, XP055498024 [A] 1-9 * abstract * DOI: http://dx.doi.org/10.1038/gt.2015.45 | [A] - KELLER BRIAN A ET AL, "Oncolytic viruses-immunotherapeutics on the rise", JOURNAL OF MOLECULAR MEDICINE, SPRINGER VERLAG, DE, vol. 94, no. 9, doi:10.1007/S00109-016-1453-9, ISSN 0946-2716, (20160804), pages 979 - 991, (20160804), XP036037794 [A] 1-9 * abstract * * page 986, column 2, paragraph 3 - page 988, column 2, paragraph 1; figures 1-3; table 1 * DOI: http://dx.doi.org/10.1007/s00109-016-1453-9 | [T] - MATHILDE FEIST ET AL, "Oncolytic virus promotes tumor-reactive infiltrating lymphocytes for adoptive cell therapy", CANCER GENE THERAPY, GB, (20200707), doi:10.1038/s41417-020-0189-4, ISSN 0929-1903, XP055742365 [T] * the whole document * DOI: http://dx.doi.org/10.1038/s41417-020-0189-4 | International search | [Y]US2010303714 (KIRN DAVID [US]) [Y] 1-6, 19-24, 62 * entire document *; | [XY]US2016000842 (SONG XIAO-TONG [US], et al) [X] 47, 48, 60, 61 * entire document * [Y] 1-6, 19-24, 27-29, 62; | [A]WO2016070136 (MASSACHUSETTS INST TECHNOLOGY [US], et al) [A] 1-6, 19-24, 27-29, 47, 48, 60-62 * entire document *; | [A]US2016250267 (UCHIDA HIROAKI [JP], et al) [A] 1-6, 19-24, 27-29, 47, 48, 60-62* entire document *; | [A]WO2016174200 (PSIOXUS THERAPEUTICS LTD [GB]) [A] 1-6, 19-24, 27-29, 47, 48, 60-62 * entire document *; | [Y] - PAN et al., "Cancer Immunotherapy Using a Membrane-bound Interleukin-12 With B7-1 Transmembrane and Cytoplasmic Domains", Molecular Therapy, (20120214), vol. 20, no. 5, pages 927 - 937, XP055327744 [Y] 6, 24, 27-29 * . entire document * DOI: http://dx.doi.org/10.1038/mt.2012.10 | [A] - LIU et al., "CXCL11-Armed Oncolytic Poxvirus Elicits Potent Antitumor Immunity and Shows Enhanced Therapeutic Efficacy", Oncolmmunology, (20151029), vol. 5, no. 3, pages 1 - 10, XP055529957 [A] 1-6, 19-24, 27-29, 47, 48, 60-62 * . entire document * DOI: http://dx.doi.org/10.1080/2162402X.2015.1091554 |